Suzuki A, Takahashi T, Okuno Y, Fukumoto M, Fukui H, Koishihara Y, Ohsugi Y, Ohno Y, Imura H
Second Department of Internal Medicine, Kyoto University, Japan.
Leuk Res. 1991;15(11):1043-50. doi: 10.1016/0145-2126(91)90110-f.
Although an autocrine growth mechanism through interleukin 6 has been advocated in human myeloma cells, reports of IL-6 production by cells from established myeloma cell lines are rare. In the present study, we examined whether or not a minute amount of interleukin 6 is produced in 4 human myeloma cell lines. IL-6 production was not detected in any of the 4 lines by enzyme immunoassay, bioassay with two interleukin 6-dependent murine hybridoma cell lines and Northern hybridization. However, we detected interleukin 6 mRNA in one (U266) of the 4 lines by the reverse transcriptase-polymerase chain reaction. Nevertheless, the proliferation of all 4 lines was not inhibited by an anti-interleukin 6 antibody. These results suggest that autocrine stimulation by interleukin 6 is not involved in the majority of human myeloma cell lines.
尽管有人主张人骨髓瘤细胞存在通过白细胞介素6的自分泌生长机制,但关于已建立的骨髓瘤细胞系细胞产生白细胞介素6的报道却很少。在本研究中,我们检测了4种人骨髓瘤细胞系是否产生微量白细胞介素6。通过酶免疫测定、用两种依赖白细胞介素6的小鼠杂交瘤细胞系进行生物测定以及Northern杂交,在这4种细胞系中均未检测到白细胞介素6的产生。然而,通过逆转录聚合酶链反应,我们在4种细胞系中的一种(U266)中检测到了白细胞介素6 mRNA。尽管如此,抗白细胞介素6抗体并未抑制所有4种细胞系的增殖。这些结果表明,白细胞介素6的自分泌刺激在大多数人骨髓瘤细胞系中并不起作用。